CN Stock MarketDetailed Quotes

002589 Realcan Pharmaceutical Group

Watchlist
  • 3.41
  • +0.04+1.19%
Market Closed Nov 8 15:00 CST
5.13BMarket Cap126.30P/E (TTM)

Realcan Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Realcan Pharmaceutical Group Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
2.02B
--
-0.03%
Net Income
--
11.70M
--
+185.04%
Analyst Rating
No Data

Realcan Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 30, 20192019/Q18.742B / 7.504B--
DatePeriodRevenue/EstimateEarnings Call
Apr 30, 20192019/Q18.742B / 7.504B--

Realcan Pharmaceutical Group Earnings Reports

  • Ruikang Pharmaceutical: Report for the third quarter of 2024

    Oct 31 00:00

  • Ruikang Pharmaceutical: 2024 Semi-Annual Report Summary

    Aug 27 00:00

  • Ruikang Pharmaceutical: 2024 Semi-Annual Report

    Aug 27 00:00

  • Realcan Pharmaceutical Group: 2024 First Quarter Report

    Apr 30 00:00

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data